Auger-Buendia M A, Hamelin R, Tavitian A
Biochim Biophys Acta. 1978 Nov 21;521(1):241-50. doi: 10.1016/0005-2787(78)90267-8.
The adenosine analogue toyocamycin inhibits the maturation of ribosomal RNA, but permits the synthesis of other RNA species, including 45 S preribosomal RNA. In this work, the dose vs. response analysis of rRNA processing upon toyocamycin treatment of L5178Y cells is studied. It is shown that the latter steps of rRNA processing are more affected than the earlier. The mechanism responsible for the lack of conversion of toyocamycin-containing 45 S RNA into mature rRNA has not yet been elucidated. In order to investigate whether protein factors are involved in this mechanism, the effects of toyocamycin on the ability of preribosomal RNA to bind proteins and on the assembly of nucleolar preribosomes are investigated. The analogue allows the formation and the accumulation, in the nucleolus, of ribonucleoprotein complexes which contain 45 S RNA and newly synthesized proteins, but cannot be converted to mature ribosomal subunits. These complexes are not clearly distinguishable from 80 S particles synthesized in the absence of toyocamycin, with respect to their sedimentation rate in linear sucrose gradients, to their protein/RNA ratio and to their density measured in metrizamide gradients.
腺苷类似物丰加霉素可抑制核糖体RNA的成熟,但能使包括45S前核糖体RNA在内的其他RNA种类得以合成。在这项研究中,对丰加霉素处理L5178Y细胞后rRNA加工过程的剂量反应分析进行了研究。结果表明,rRNA加工的后期步骤比早期受到的影响更大。丰加霉素所包含的45S RNA无法转化为成熟rRNA的原因尚未阐明。为了研究蛋白质因子是否参与这一机制,对丰加霉素对前核糖体RNA结合蛋白质能力以及核仁前核糖体组装的影响进行了研究。该类似物可使含有45S RNA和新合成蛋白质的核糖核蛋白复合物在核仁中形成并积累,但无法转化为成熟的核糖体亚基。就其在线性蔗糖梯度中的沉降速率、蛋白质/RNA比率以及在甲泛葡胺梯度中测得的密度而言,这些复合物与在无丰加霉素情况下合成的80S颗粒并无明显差异。